Rhythm Pharmaceuticals (RYTM) Update / Briefing July 09, 2025 08:00 AM ET Speaker0 Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Top Line Results from Phase II Trial Evaluating Bivamilagon in Acquired Hypothalamic Obesity Conference Call. At this time, participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask the questions in the session, you will need to press 11 on your telephone. You will then hear an auto ...